Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387361570> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- W4387361570 abstract "Abstract Disclosure: C.R. Peixe: None. D. López-Presa: None. M. Bugalho: None. P. Marques: None. Introduction: Giant prolactinomas are rare, accounting for only 2–3% of all prolactinomas. Although benign, several challenges may emerge at diagnosis and during their management. Case: A 38-yr man was incidentally diagnosed with a large skull base tumor on CT-scan undertaken due to head trauma. MRI showed a 55x33mm skull base mass, involving the clivus and sellar/parasellar regions, with bilateral cavernous sinus invasion. A chordoma was suspected leading to a transnasal biopsy, which revealed a PIT1+-plurihormonal pituitary adenoma. His serum prolactin levels were then assessed, which were markedly elevated at 50,414ng/mL (NR:4-15), with concomitant raised IGF-1 at 323ng/mL (NR:101-221). He was then referred to our Endocrine department. Retrospectively, there was a 3-yr history of erectile dysfunction, decreased libido, and infertility, although his testosterone levels were within reference range (307ng/dL; NR:240-830), and sperm analysis parameters were normal. He commenced on low dose cabergoline (0.5mg/week) and two months later clinical improvement was noted, accompanied by a marked reduction of prolactin (830ng/mL) and tumor shrinkage. He remains on cabergoline for ten months, and his latest prolactin and IGF-1 levels were, respectively, 496 and 224ng/mL. In the light of patient’s normal spermogram and restored sexual function, the couple has been referred to the Fertility clinic. Conclusions: The differential diagnosis of large skull base tumors, particularly those affecting sellar/clival regions, must always include prolactinoma, hence serum prolactin should be measured keeping in mind the possible occurrence of hook effect. Most giant prolactinomas respond to dopamine agonists, which should be considered as a first-line therapy, with marked reductions in both prolactin and tumor size often seen within the first weeks of treatment. GH-cosecretion may also ameliorate/normalize with dopamine agonists. In prolactinoma patients, infertility may or may not be directly related with hyperprolactinemia, hence a careful assessment is required, and its management may imply assisted reproductive techniques. Presentation: Friday, June 16, 2023" @default.
- W4387361570 created "2023-10-06" @default.
- W4387361570 creator A5040727669 @default.
- W4387361570 creator A5049712000 @default.
- W4387361570 creator A5050884911 @default.
- W4387361570 creator A5077121382 @default.
- W4387361570 date "2023-10-01" @default.
- W4387361570 modified "2023-10-06" @default.
- W4387361570 title "FRI319 Diagnostic And Management Challenges In A Patient With A Giant Pituitary Lactosomatotroph Adenoma" @default.
- W4387361570 doi "https://doi.org/10.1210/jendso/bvad114.1254" @default.
- W4387361570 hasPublicationYear "2023" @default.
- W4387361570 type Work @default.
- W4387361570 citedByCount "0" @default.
- W4387361570 crossrefType "journal-article" @default.
- W4387361570 hasAuthorship W4387361570A5040727669 @default.
- W4387361570 hasAuthorship W4387361570A5049712000 @default.
- W4387361570 hasAuthorship W4387361570A5050884911 @default.
- W4387361570 hasAuthorship W4387361570A5077121382 @default.
- W4387361570 hasBestOaLocation W43873615701 @default.
- W4387361570 hasConcept C126322002 @default.
- W4387361570 hasConcept C141071460 @default.
- W4387361570 hasConcept C142724271 @default.
- W4387361570 hasConcept C2776741419 @default.
- W4387361570 hasConcept C2777047896 @default.
- W4387361570 hasConcept C2777428134 @default.
- W4387361570 hasConcept C2778918492 @default.
- W4387361570 hasConcept C2779064019 @default.
- W4387361570 hasConcept C2779300802 @default.
- W4387361570 hasConcept C2779318953 @default.
- W4387361570 hasConcept C2779832395 @default.
- W4387361570 hasConcept C2780801072 @default.
- W4387361570 hasConcept C71315377 @default.
- W4387361570 hasConcept C71924100 @default.
- W4387361570 hasConceptScore W4387361570C126322002 @default.
- W4387361570 hasConceptScore W4387361570C141071460 @default.
- W4387361570 hasConceptScore W4387361570C142724271 @default.
- W4387361570 hasConceptScore W4387361570C2776741419 @default.
- W4387361570 hasConceptScore W4387361570C2777047896 @default.
- W4387361570 hasConceptScore W4387361570C2777428134 @default.
- W4387361570 hasConceptScore W4387361570C2778918492 @default.
- W4387361570 hasConceptScore W4387361570C2779064019 @default.
- W4387361570 hasConceptScore W4387361570C2779300802 @default.
- W4387361570 hasConceptScore W4387361570C2779318953 @default.
- W4387361570 hasConceptScore W4387361570C2779832395 @default.
- W4387361570 hasConceptScore W4387361570C2780801072 @default.
- W4387361570 hasConceptScore W4387361570C71315377 @default.
- W4387361570 hasConceptScore W4387361570C71924100 @default.
- W4387361570 hasIssue "Supplement_1" @default.
- W4387361570 hasLocation W43873615701 @default.
- W4387361570 hasOpenAccess W4387361570 @default.
- W4387361570 hasPrimaryLocation W43873615701 @default.
- W4387361570 hasRelatedWork W1979791004 @default.
- W4387361570 hasRelatedWork W2023874286 @default.
- W4387361570 hasRelatedWork W2062130512 @default.
- W4387361570 hasRelatedWork W2119530081 @default.
- W4387361570 hasRelatedWork W2277165767 @default.
- W4387361570 hasRelatedWork W2511655047 @default.
- W4387361570 hasRelatedWork W2621185154 @default.
- W4387361570 hasRelatedWork W2644842857 @default.
- W4387361570 hasRelatedWork W2888691455 @default.
- W4387361570 hasRelatedWork W4307839718 @default.
- W4387361570 hasVolume "7" @default.
- W4387361570 isParatext "false" @default.
- W4387361570 isRetracted "false" @default.
- W4387361570 workType "article" @default.